hVIVO has announced the presentation of positive data from three newly developed human challenge models at the 10th European Scientific Working Group on Influenza (ESWI) Conference in Valencia, and the World Vaccine Congress Europe in Amsterdam (both meetings October 2025). These conferences are two of the most influential scientific meetings in the industry and the data presented on hMPV, RSV B, and SARS-CoV-2 Omicron models demonstrate the result of intensive work on these programmes over the ....
